Invene Earns No. 2350 Ranking on 2025 Inc. 5000 List of America's Fastest-Growing Private Companies

‍

‍

Healthcare-focused AI and engineering firm recognized for rapid growth amid increasing demand for specialized technology solutions

‍

Invene, a leading healthcare-focused innovation and AI solutions firm, today announced it has earned the rank of No. 2350 on the 2025 Inc. 5000 list of the fastest-growing private companies in America. The prestigious ranking recognizes companies that have demonstrated exceptional growth while navigating economic uncertainty and market challenges.

‍

The Inc. 5000 list provides a comprehensive look at the most successful companies within America's independent, entrepreneurial business sector. Previous Inc. 5000 honorees include industry leaders such as Microsoft, Meta, Oracle, and Patagonia during their high-growth phases.

‍

Strategic Growth Driven by Healthcare Industry Demand

‍

The recognition comes as healthcare organizations face unprecedented pressure to implement advanced technologies while maintaining strict regulatory compliance. Invene's growth trajectory reflects increasing demand from multiple healthcare segments seeking specialized expertise in AI implementation, system modernization, and regulatory-compliant innovation.

‍

Key growth drivers during the recognition period include:

• Expansion across five healthcare segments: providers, payers, HealthTech companies, medical device manufacturers, and life sciences firms
• Strategic acquisition of Guidea, bringing clinical UX and product strategy capabilities to create seamless concept-to-deployment solutions
• Increased demand for GenAI implementation consulting from PE-backed organizations under board pressure to adopt AI technologies
• Growing need for specialized healthcare technology expertise as organizations pursue 3-5 year exit strategies

‍

The recognition reflects the trust healthcare organizations place in Invene's team to solve their most complex technology challenges and demonstrates the critical need for specialized expertise in healthcare technology innovation.

‍

Addressing Complex Healthcare Technology Challenges

‍

Since its founding in 2018, Invene has established itself as the go-to partner for healthcare organizations requiring sophisticated technology solutions that meet strict regulatory and compliance requirements. The company's team possesses deep domain expertise in healthcare-specific technologies and regulations including HL7, HIPAA, HITRUST, FHIR, and emerging AI frameworks.

‍

Invene's exclusive focus on healthcare and deep understanding of the unique challenges in this industry sets the company apart from traditional technology consulting firms. Rather than just building technology, Invene solves problems that directly impact patient care, operational efficiency, and organizational growth in a highly regulated environment.

‍

The company's comprehensive approach spans from strategic discovery and validation through full-scale application development and deployment. Invene’s clients receive solutions that meet both technical requirements and regulatory compliance standards. Through the integration of Guidea's product strategy and UX expertise with Invene's engineering capabilities, clients now benefit from a unified team with expanded fullstack healthcare AI capabilities.

‍

Looking Ahead: Continued Innovation in Healthcare Technology

‍

The recognition comes during a critical period for healthcare technology adoption, particularly around artificial intelligence implementation. Many healthcare organizations struggle with use case prioritization, board communication, and building organizational capabilities for AI adoption while maintaining regulatory compliance.

‍

Invene's clients face challenges that require both deep technical expertise and comprehensive understanding of healthcare regulations, compliance frameworks, and operational realities. This recognition reflects the company's success in delivering solutions that drive real business value while meeting the stringent requirements that define healthcare technology.

‍

As healthcare organizations continue to navigate complex technology landscapes while preparing for strategic growth and potential exits, Invene's specialized expertise positions the company for continued expansion in serving this critical market segment.

‍

About the Inc. 5000 List

‍

The Inc. 5000 methodology ranks companies based on percentage revenue growth from 2021 to 2024. To qualify, companies must be U.S.-based, privately held, for-profit, and independent, with minimum revenue thresholds of $100,000 in 2021 and $2 million in 2024.

‍

This year's honorees demonstrated exceptional resilience and growth amid economic challenges, with the median three-year revenue growth rate among the top 500 companies reaching 1,552 percent. Collectively, these companies added more than 48,678 jobs to the U.S. economy over the past three years.

‍

About Invene

‍

Invene is a healthcare-focused innovation and AI solutions firm that transforms complex ideas into practical, impactful, and compliant technology solutions. Founded in 2018 by James Griffin with a 20-year vision to become the nation's leading healthcare consulting firm, the company operates with a fully remote, 100% USA-based team and specializes exclusively in healthcare.

‍

Invene's leadership team combines entrepreneurial vision, engineering expertise, and product design acumen, including CEO James Griffin (Forbes Next 1000 honoree), VP of Engineering Alex Melton, Chief Product Officer Theresa Neil (author of two O'Reilly books and Top Designer in Tech by Business Insider), and VP of Product Rebecca Loar.

‍

For more information, contact us or book a strategy call.

‍